���构特征与受体作用机制 — 2026 Update

By Editorial Desk · published 2025-10-23 · last reviewed 2025-11-26 · Wiki

GLP-1 receptor is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2025-11-26. Numbers and descriptions here follow the published literature rather than marketing material.

结构特征与受体作用机制

序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。

Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物，其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代，使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸，进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链，该侧链赋予分子与血浆白蛋白结合的能力。

Handling, Storage, and Analytical Verification

Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.

Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.

Semaglutide at a glance

Background and Molecular Profile

Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.

The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L cells after food intake. The molecule is a 31-amino-acid backbone modified at three positions to resist cleavage by dipeptidyl peptidase-4, the enzyme that degrades native GLP-1 within minutes. A lysine residue at position 26 carries a linker and a C18 fatty diacid, which promotes binding to serum albumin and slows renal clearance. These changes extend the circulating half-life from roughly two minutes to about one week in humans.

Related pages on this site

• Practical dataset
• Seasonal casebook
• Proven update
• Quality dataset
• Automated index
• Scheduled archive
• Gradual overview
• Simple checklist

Background and Molecular Design

The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.

Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.

Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.

Background and Mechanism of Action

Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.

Supporting material

Mianserin, sold as Tolvon and other brand names, is an atypical antidepressant used primarily for treating depression in Europe and other countries. It is a tetracyclic antidepressant (TeCA) and is closely related to mirtazapine in terms of chemical structure, actions, and effects, although mianserin has greater noradrenergic activity and less 5-HT3 receptor antagonism.

=== Role in aging === The relationship between RAGE signaling and aging has been a growing focus of research, particularly in the context of cellular senescence and inflammaging—chronic, low-grade inflammation associated with aging. RAGE has been implicated in promoting cellular senescence, a permanent state of cell-cycle arrest, which contributes to the accumulation of dysfunctional cells that secrete pro-inflammatory factors, collectively referred to as the senescence-associated secretory phenotype (SASP). A study conducted in 2022 demonstrated that the activation of RAGE by AGEs in aged tissues leads to the accumulation of senescent cells, thereby exacerbating tissue inflammation and contributing to age-related diseases. This study also noted that the upregulation of RAGE in aged cells increased the secretion of SASP factors, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), both of which are key mediators of inflammaging. Another recent investigation from 2023 found that mice deficient in RAGE exhibited reduced markers of senescence and systemic inflammation compared to age-matched controls, suggesting that targeting RAGE signaling may be a promising approach to mitigate the adverse effects of aging and extend healthspan. These findings highlight the role of RAGE as a crucial regulator of the inflammatory milieu associated with aging, providing potential avenues for therapeutic interventions aimed at reducing age-related inflammatory diseases.

=== Sleep apnea === Sleep apnea is a condition characterized by repeated interruptions in breathing during sleep, significantly affecting the flow of blood through the brain's blood vessels. These interruptions cause intermittent hypoxia, leading to vascular changes such as the constriction of cerebral blood vessels, thereby impacting overall brain blood flow. Sleep apnea can also result in reduced blood flow in the ciliary artery area, contributing to the development of NAION through various mechanisms. The results of a retrospective study investigating high altitude (7,000-9,000 feet) as a potential risk factor for NAION suggested that high-altitude-associated NAION might be linked to undiagnosed obstructive sleep apnea. The study concluded that NAION could occur under high-altitude conditions, often in younger individuals with obstructive sleep apnea and "disc-at-risk". Each apnea episode typically causes temporary increases in blood pressure and heart rate, leading to fluctuations that can result in irregular blood flow to the brain. This may cause long-term changes in the structure and function of cerebral blood vessels. The brain's mechanism for maintaining constant blood flow despite changes in systemic blood pressure, known as cerebral autoregulation, can be impaired by sleep apnea. This impairment results in periods of both reduced and excessive cerebral blood flow. Repeated airway obstruction during sleep leads to intermittent hypoxia, causing oxidative stress and damaging endothelial cells of blood vessels, including those supplying the optic nerve head.

Sources: en.wikipedia.org

Notes from published material

==== Indonesia ==== In 2008, 7-Eleven announced plans to expand its business in Indonesia through a master franchise agreement with Modern Sevel Indonesia. Modern Sevel Indonesia's initial plans were to focus on opening stores in Jakarta, targeting densely populated commercial and business areas. There were 190 7-Eleven stores in Indonesia as of 2014 which then reduced to only 166 stores in September 2016. 7-Eleven then closed its doors in Indonesia in 2017, citing low sales.

=== Distribution, phenology, and ecology === Fungarium records provide a historical record of global biodiversity that can be linked to environmental change. Georeferenced metadata allow researchers to connect specimens to historical climate and land-use databases such as WorldClim. Analysis of collection dates in Europe has revealed delays in the autumnal fruiting season and a general widening of the season for saprotrophic fungi. Specimens have also been used to trace invasive species; for example, the introduction and spread of Amanita phalloides in the western United States was reconstructed using DNA from collections spanning a century. Stable carbon and nitrogen isotope analysis of sporocarps in the genus Ramaria has confirmed their nutritional modes and roles in carbon cycling. Although many historical records lack geographic coordinates or contain only vague locality descriptions, retrospective georeferencing can make older specimens more useful for spatial analyses such as species distribution modelling, provided the associated uncertainty is documented.

Protons are spin-⁠1/2⁠ fermions and are composed of three valence quarks, making them baryons (a sub-type of hadrons). The two up quarks and one down quark of a proton are held together by the strong force, mediated by gluons. A modern perspective has a proton composed of the valence quarks (up, up, down), the gluons, and transitory pairs of sea quarks. Protons have a positive charge distribution, which decays approximately exponentially, with a root mean square charge radius of about 0.8 fm. Protons and neutrons are both nucleons, which may be bound together by the nuclear force to form atomic nuclei. The nucleus of the most common isotope of the hydrogen atom (with the chemical symbol "H") is a lone proton. The nuclei of the heavy hydrogen isotopes deuterium and tritium contain one proton bound to one and two neutrons, respectively. All other types of atomic nuclei are composed of two or more protons and various numbers of neutrons.

=== Bispecific antibodies and radiolabelled haptens === The beginning of the pretargeting concept was based on bispecific antibodies which were able to bind a specific target antigen and a radiolabelled hapten. Possible was this approach because of the development of monoclonal Antibodies which could be connected to radiometal chelates. Also connecting two haptens via a two amino acid linker resulted in an enhancement effect of the affinity, which improved the uptake and retention of the radiolabelled compound without affecting the rapid clearance. Limiting factor of this approach were the slow binding constant which was rarely higher than 10−10 M, amongst other reasons.

Sources: en.wikipedia.org

Further detail

=== Phenylbutyrate therapy === Sodium phenylacetate/benzoate or sodium phenylbutyrate has been shown to reduce BCAA in a clinical trial done February 2011. Phenylbutyrate treatment reduced the blood concentration of BCAA and their corresponding BCKA in certain groups of MSUD patients and may be a possible adjunctive treatment.

=== Gait === The plantar fascia also has an important role in dynamic function during gait. It was found the plantar fascia continuously elongated during the contact phase of gait. It went through rapid elongation before and immediately after mid-stance, reaching a maximum of 9% to 12% elongation between mid-stance and toe-off.‍ During this phase the plantar fascia behaves like a spring, which may assist in conserving energy. In addition, the plantar fascia has a critical role in normal mechanical function of the foot, contributing to the "windlass mechanism". When the toes are dorsiflexed in the propulsive phase of gait, the plantar fascia becomes tense, resulting in elevation of the longitudinal arch and shortening of the foot (see 3A). One can liken this mechanism to a cable being wound around the drum of a windlass (see 3B); the plantar fascia being the cable, the metatarsal head the drum, and the handle, the proximal phalanx.

=== June === 2 June – Diane Abbott confirms she will run as Labour's candidate for Hackney North and Stoke Newington at the general election. Media, including BBC News, report that Derbyshire Police are reviewing allegations of election fraud relating to "concerns around marketing material" posted on social media by Robert Largan, MP and Conservative candidate for High Peak. 3 June – Nigel Farage announces that, contrary to his statement earlier in the campaign, he will stand for Parliament in Clacton, and that he has resumed leadership of Reform UK. The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (England, Wales and Scotland) Order 2024 is scheduled to come into force. The first 2024 leaders debate takes place in Scotland, with the leaders of Scotland's four main political parties taking part in a debate on STV. The UK government tells the High Court it has delayed the start date for flights sending asylum seekers to Rwanda to 24 July. The Welsh Government shelves plans to legislate for shorter school summer holidays in Wales until after the next Senedd election. 4 June – ITV airs Sunak v Starmer: The ITV Debate, a head-to-head election debate between Rishi Sunak and Keir Starmer presented by Julie Etchingham. During the debate Sunak says that Labour has a £38bn spending shortfall which would require it to raise taxes by £2,000 for the average household by the end of the next parliament.

== History == Tentatively called "radium F", polonium was discovered by Marie and Pierre Curie in July 1898, and was named after Marie Curie's native land of Poland (Latin: Polonia). Poland at the time was under Russian, German, and Austro-Hungarian partition, and did not exist as an independent country. It was Curie's hope that naming the element after her native land would publicize its lack of independence. Polonium may be the first element named to highlight a political controversy. This element was the first one discovered by the Curies while they were investigating the cause of pitchblende radioactivity. Pitchblende, after removal of the radioactive elements uranium and thorium, was more radioactive than the uranium and thorium combined. This spurred the Curies to search for additional radioactive elements. They first separated out polonium from pitchblende in July 1898, and five months later, also isolated radium. German scientist Willy Marckwald successfully isolated 3 milligrams of polonium in 1902, though at the time he believed it was a new element, which he dubbed "radio-tellurium", and it was not until 1905 that it was demonstrated to be the same as polonium. In the United States, polonium was produced as part of the Manhattan Project's Dayton Project during World War II. Polonium and beryllium were the key ingredients of the 'Urchin' initiator at the center of the bomb's spherical pit. 'Urchin' initiated the nuclear chain reaction at the moment of prompt-criticality to ensure that the weapon did not fizzle. 'Urchin' was used in early U.S.

=== Synthetic genomics === The formation of animals with a chemically manufactured (minimal) genome is another facet of synthetic biology that is highlighted by synthetic genomics. This area of synthetic biology has been made possible by ongoing advancements in DNA synthesis technology, which now makes it feasible to produce DNA molecules with thousands of base pairs at a reasonable cost. The goal is to combine these molecules into complete genomes and transplant them into living cells, replacing the host cell's genome and reprogramming its metabolism to perform different functions. Scientists have previously demonstrated the potential of this approach by creating infectious viruses by synthesising the genomes of multiple viruses. These significant advances in science and technology triggered the initial public concerns concerning the risks associated with this technology. A simple genome might also work as a "chassis genome" that could be enlarged quickly by gene inclusion created for particular tasks. Such "chassis creatures" would be more suited for the insertion of new functions than wild organisms since they would have fewer biological pathways that could potentially conflict with the new functionalities in addition to having specific insertion sites. Synthetic genomics strives to create creatures with novel "architectures," much like the bioengineering method. It adopts an integrative or holistic perspective of the organism.

Sources: en.wikipedia.org

Frequently asked questions